FDA inspection
Invitrx Therapeutics Inc.: FDA inspection ending Mar 22, 2022
FDA inspection 1165854 · Official Action Indicated (OAI) · Lake Forest, CA
Key facts
| Inspection ID | 1165854 |
|---|---|
| Firm | Invitrx Therapeutics Inc. |
| FEI number | 3015252551 |
| Address | 20503 Crescent Bay Dr |
| City | Lake Forest |
| State | CA |
| ZIP | 92630 |
| Country | United States |
| Fiscal year | 2022 |
| Inspection end date | Mar 22, 2022 |
| Classification | Official Action Indicated (OAI) |
| Project area | Human Cellular, Tissue, and Gene Therapies |
| Product type | Biologics |
| Warning letter | 630712 |
At a glance
- 10–99 Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data